Suppr超能文献

一项正念认知疗法治疗双相情感障碍的随机对照试验。

A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder.

机构信息

School of Psychiatry, University of New South Wales, Sydney, Australia.

出版信息

Acta Psychiatr Scand. 2013 May;127(5):333-43. doi: 10.1111/acps.12033. Epub 2012 Dec 9.

Abstract

OBJECTIVE

To compare the efficacy of mindfulness-based cognitive therapy (MBCT) plus treatment as usual (TAU) to TAU alone for patients with bipolar disorder over a 12-month follow-up period.

METHOD

Participants with a DSM-IV diagnosis of bipolar disorder were randomly allocated to either MBCT plus TAU or TAU alone. Primary outcome measures were time to recurrence of a DSM-IV major depressive, hypomanic or manic episode; the Montgomery-Åsberg Depression Rating Scale (MADRS); and Young Mania Rating Scale (YMRS). Secondary outcome measures were number of recurrences, the Depression Anxiety Stress Scales (DASS), and the State Trait Anxiety Inventory (STAI).

RESULTS

Ninety-five participants with bipolar disorder were recruited to the study (MBCT = 48; TAU = 47). Intention-to-treat (ITT) analysis found no significant differences between the groups on either time to first recurrence of a mood episode or total number of recurrences over the 12-month period. Furthermore, there were no significant between-group differences on the MADRS or YMRS scales. A significant between-group difference was found in STAI - state anxiety scores. There was a significant treatment by time interaction for the DAS - achievement subscale.

CONCLUSION

While MBCT did not lead to significant reductions in time to depressive or hypo/manic relapse, total number of episodes, or mood symptom severity at 12-month follow-up, there was some evidence for an effect on anxiety symptoms. This finding suggests a potential role of MBCT in reducing anxiety comorbid with bipolar disorder.

摘要

目的

比较正念认知疗法(MBCT)联合治疗与单独治疗在 12 个月随访期间对双相障碍患者的疗效。

方法

符合 DSM-IV 双相障碍诊断的参与者被随机分配至 MBCT 联合治疗或单独治疗。主要结局指标为复发 DSM-IV 重性抑郁、轻躁狂或躁狂发作的时间;蒙哥马利-阿斯伯格抑郁评定量表(MADRS)和杨氏躁狂评定量表(YMRS)。次要结局指标为复发次数、抑郁焦虑应激量表(DASS)和状态特质焦虑量表(STAI)。

结果

本研究共招募了 95 名双相障碍患者(MBCT = 48;TAU = 47)。意向治疗(ITT)分析发现,两组在首次心境发作复发时间或 12 个月内复发总次数上均无显著差异。此外,MADRS 和 YMRS 量表上两组间也无显著差异。STAI - 状态焦虑评分存在显著的组间差异。DAS - 成就分量表存在显著的治疗时间交互作用。

结论

虽然 MBCT 并未导致抑郁或轻躁狂/躁狂复发时间、发作次数或心境症状严重程度在 12 个月随访时显著减少,但有证据表明对焦虑症状有一定的影响。这一发现表明 MBCT 在减少双相障碍共病焦虑方面可能有一定作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验